fig1
Figure 1. Gut-derived imidazole propionate (ImP) activates the imidazoline receptor 1 (I1R) and the mTOR pathway in myeloid cells, driving immune responses and vascular inflammation, which contribute to the progression of atherosclerosis. Created with BioGDP.com.
